SMITHS FALLS, ON, June 24, 2017 /CNW/ - Earlier this week, Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") provided a global operational update to keep shareholders and other stakeholders apprised of operational developments as they relate to international milestones and innovative new product types. With a rapidly growing medical market in Canada, increasing international demand profiles and the fast-approaching move towards an adult-use access market in Canada, a reliable, diversified and exponentially larger footprint will be essential.
SMITHS FALLS, ON, June 20, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth") will release its financial results for the fourth quarter and fiscal year ended March 31, 2017 on June 27, 2017.
YORKTON, SK, May 2, 2017 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") is pleased to announce the closing of the previously announced acquisition of rTrees Producers Limited Inc., a late-stage applicant in Health Canada's Access to Cannabis for Medical Purposes Regulations. If and when licensed, the site will operate as Tweed Grasslands ("Tweed Grasslands") and become the newest facility to join Canada's largest network of legal, licensed cannabis producers owned and operated by Canopy Growth.
SMITHS FALLS, ON, April 13, 2017 /CNW/ - Later today the Canadian government is expected to table legislation intended to end decades of cannabis prohibition. Looking forward to a legal recreational market made up of an ecosystem of new and exciting businesses, many of which will be introducing themselves to Canadians and their communities for the first times, Canopy Growth wishes to take the opportunity to provide an update on its social responsibility programs.
VANCOUVER, April 11, 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces that Acreage Pharms Ltd. ("Acreage Pharms") which Invictus MD has the option to now acquire 100 percent and expect to exercise in short order, begins their new cultivation cycle, having received their license to cultivate under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), they are firmly committed to patient safety and the quality of their cannabis.
VICTORIA, April 5, 2017 /CNW/ - Emerald Health Therapeutics Inc. (TSXV:EMH) ("Emerald" or the "Company") is pleased to announce its inclusion in the Horizon Medical Marijuana Life Sciences ETF (TSX:HMMJ) ("HMMJ ETF"), which began trading today and is the first ETF to offer direct exposure to North American-listed stocks that operate in the legal medical cannabis industry.